Brent Seybold - VP, Device Development

Brent Seybold joined BioCardia in 2022 and brings over 25 years of medical device expertise with organizations ranging from seed-round start-ups to established global leaders.  Brent has extensive experience transforming both disposable and implantable medical device technologies from concepts to commercial product in the fields of thrombectomy & embolic protection, chronic total occlusion, ischemic stroke, hypertension and vertebroplasty.  He has previously served in executive and technical leadership roles at companies including LuMend, Parallax Medical, Genesis Medical Interventional, Micrus Endovascular and Vascular Dynamics. Brent has a Bachelor of Science degree in Mechanical Engineering from the University of California, Davis.


Have questions?
: (800) 624-1179
Have questions?

biocardia takes a new and comprehensive
approach to heart failure

By introducing patient screening and highly-efficient delivery to stem cell therapy, the company seeks to increase the likelihood of treatment success, enabling more patients to return to the things they love.